Form 4 for EW Edwards Lifesciences
Accepted 2023-08-01 00:00:00 ET · period of report 2023-07-31 · accession 0001225208-23-007850 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-01 | 2023-07-31 | EW | Zovighian Bernard J | CEO, Dir | I - Discretionary | $83.54 | +2,559 | 47.1K | +6% | +$213.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-31 | I | A | 2,558.62 | $83.54 | 47,111.49 | D | — | — | (F1) The exact unit price to its last decimal number is $83.538983. |